Bromide

Bromide

SCHEMBL22412705

Br.CCC(=O)OC1CCCN(C(Cc2ccccc2)C(=O)Nc2c(C)cccc2C)C1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.43
▸ SCN4A P35499 2/20 0.41
▸ MAPT P10636 3/20 0.40
▸ POLB P06746 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ BCHE P06276 3/20 0.39
▸ MAOB P27338 2/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL22412426 0.83 HTT (0.50) ATMMAPTCYP3A4CYP2D6ALDH1A1
Bromide SCHEMBL22412638 0.80 HTT (0.43) ATMSCN4AMAPTCYP3A4CYP2D6
Bromide SCHEMBL22412696 0.80 ATM (0.59) ATMSCN4AMAPTPOLBLMNA
SCHEMBL22407695 0.74 ALDH1A1 (0.52) POLBLMNABCHEMAOBCYP1A2
SCHEMBL22435855 0.73 ATM (0.49) ATMSCN4AMAPTLMNACYP3A4
SCHEMBL18485512 0.68 ATM (0.68) ATMSCN4AMAPTPOLBLMNA
SCHEMBL22203980 0.68 ATM (0.63) ATMPOLBLMNACYP3A4CYP2D6
SCHEMBL18485516 0.67 ATM (0.66) ATMPOLBLMNACYP3A4CYP2D6
SCHEMBL22407724 0.67 ATM (0.66) ATMPOLBLMNACYP3A4CYP2D6
SCHEMBL25626066 0.67 LMNA (0.38) SCN4AMAPTLMNABCHECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3938345-A1 CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE Nocion Therapeutics, Inc. (US) 2022-01-19 — — EP disclosed
WO-2020185830-A1 CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE Nocion Therapeutics, Inc. (US) 2020-09-17 — — WO disclosed
Send feedback